Mucolytic Agents Can Enhance HER2 Receptor Accessibility for [(89)Zr]Trastuzumab, Improving HER2 Imaging in a Mucin-Overexpressing Breast Cancer Xenograft Mouse Model

Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging
Zéna WimanaP Flamen

Abstract

Binding of trastuzumab to HER2 receptors can be impaired by steric hindrance caused by mucin MUC4. As mucolytic drugs can breakdown disulfide bonds of mucoproteins, we checked if this approach could positively affect zirconium-89-labeled trastuzumab ([(89)Zr]T) binding/uptake. The effect of N-acetylcysteine (NAC) and MUC4 knockdown/stimulation on [(89)Zr]T binding/uptake were evaluated in MCF7(HER2-), BT474 and SKBr3(HER2+/MUC4-), and JIMT1(HER2+/MUC4+) cell lines. The results were then validated in SKBR3 and JIMT1 tumor-bearing nude mice with a microPET-CT and ex vivo analysis. Significant increases in [(89)Zr]T binding/uptake were observed in JIMT1 cells following MUC4 knockdown (62.4 ± 6.5%) and exposure to NAC (62.8 ± 19.4%). Compared to controls, mice treated with NAC showed a significant increase in [(89)Zr]T uptake in MUC4 tumors on microPET-CT (SUVmean (18.3 ± 4.7%), SUVmax (41.7 ± 8.4%)) and individual organ counting (37.3 ± 18.3%). In contrast, no significant differences were observed in SKBr3. NAC can enhance [(89)Zr]T accumulation and improve the HER2 imaging of MUC4-overexpressing tumors. The potential positive impact on trastuzumab-based treatment deserves further investigation.

References

Sep 8, 2001·Journal of Mammary Gland Biology and Neoplasia·K L CarrawayC A Carraway
Jun 29, 2002·World Journal of Urology·B P SchrierJ A Witjes
Jul 13, 2002·International Journal of Cancer. Journal International Du Cancer·Shari A Price-SchiaviKermit L Carraway
Aug 12, 2004·British Journal of Cancer·C De LorenzoG D'Alessio
Jun 3, 2005·Carcinogenesis·Claudia De LorenzoGiuseppe D'Alessio
Feb 21, 2006·Journal of the American College of Cardiology·Ali J MarianRaffaella Lombardi
Jul 17, 2007·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Danny L CostantiniRaymond M Reilly
Nov 6, 2007·Trends in Molecular Medicine·Natalia V Sergina, Mark M Moasser
May 16, 2009·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Eli C F DijkersMarjolijn N Lub-de Hooge
Dec 17, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Paula R PohlmannRay Mernaugh
Dec 29, 2009·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Thijs H Oude MunninkElisabeth G E de Vries
Jan 21, 2010·Cancer Chemotherapy and Pharmacology·April DavoliThomas L Brown
Feb 1, 2011·Biochimica Et Biophysica Acta·Partha MukhopadhyaySurinder K Batra
May 28, 2011·European Journal of Nuclear Medicine and Molecular Imaging·Floris H P van VeldenRonald Boellaard
Feb 2, 2012·International Journal of Breast Cancer·Gabriel L Fiszman, María A Jasnis

❮ Previous
Next ❯

Citations

Oct 5, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·María F MercoglianoRoxana Schillaci
Feb 3, 2016·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Geraldine GebhartZena Wimana
Mar 24, 2020·Chemical Reviews·Weijun WeiWeibo Cai

❮ Previous
Next ❯

Related Concepts